We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Moxonidine Impurity 5
N-Nitroso Moxonidine Impurity 5
CAT No SRC-N014121
CAS No NA
Mol.F. C10H10Cl2N6O2
Mol.Wt. 317.1g/mol
INV STATUS IN STOCK
N-Nitroso Dihexyl Aminoquat Diiodide
N-Nitroso Dihexyl Aminoquat Diiodide
CAT No SRC-N014122
CAS No NA
Mol.F. C18H42I2N4O
Mol.Wt. 330.56 g/mol and 584.37 g/mol
INV STATUS IN STOCK
N-Nitroso Desvenlafaxine Impurity
N-Nitroso Desvenlafaxine Impurity
CAT No SRC-N014123
CAS No 3017268-48-0
Mol.F. C15H22N2O3
Mol.Wt. 278.4g/mole
INV STATUS IN STOCK
N-Nitroso-Amoxapine
N-Nitroso-Amoxapine
CAT No SRC-N014124
CAS No NA
Mol.F. C17H15ClN4O2
Mol.Wt. 342.8g/mol
INV STATUS IN STOCK
Valsartan Impurity K | N-Nitroso Valsartan Impurity 1
Valsartan Impurity K | N-Nitroso Valsartan Impurity 1
CAT No SRC-N014125
CAS No 2254485-68-0
Mol.F. C19H20N6O3
Mol.Wt. 380.4g/mol
INV STATUS IN STOCK
N-Nitrosodiisopropanolamine [NDIPLA]
N-Nitrosodiisopropanolamine [NDIPLA]
CAT No SRC-N014126
CAS No 53609-64-6
Mol.F. C6H14N2O3
Mol.Wt. 162.2g/mol
INV STATUS IN STOCK
Mebeverine Nitroso Impurity 1
Mebeverine Nitroso Impurity 1
CAT No SRC-N014127
CAS No NA
Mol.F. C23H30N2O6
Mol.Wt. 430.5g/mol
INV STATUS IN STOCK
Mebeverine Nitroso Impurity 2
Mebeverine Nitroso Impurity 2
CAT No SRC-N014128
CAS No NA
Mol.F. C15H22N2O5
Mol.Wt. 310.4g/mol
INV STATUS IN STOCK
N-Nitroso Mirabegron EP Impurity F | Mirabegron Nitroso Impurity 2
N-Nitroso Mirabegron EP Impurity F | Mirabegron Nitroso Impurity 2
CAT No SRC-N014129
CAS No 3032026-53-9
Mol.F. C16H17N3O4
Mol.Wt. 315.3g/mol
INV STATUS IN STOCK
N-Nitroso Propranolol
N-Nitroso Propranolol
CAT No SRC-N014130
CAS No 84418-35-9
Mol.F. C16H20N2O3
Mol.Wt. 288.3g/mol
INV STATUS IN STOCK

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.